Asia-Pacific’s medical devices industry saw a drop of 48.89% in deal activity during October 2022, when compared with the last 12-month average, led by Chende Capital, SoftBank Vision Fund 2, Yiheng Capital Partners, Yuanyi Capital and Zhongwei Capital HoldingLimited’s $100m venture financing of stake in Xunshi Technology, according to GlobalData’s deals database.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

A total of 23 medical devices industry deals worth $189.1m were announced for the region in October 2022, against the 12-month average of 45 deals.

Of all the deal types, venture financing saw most activity in October 2022 with 21 transactions, representing a 91.3% share for the region.

In second place was M&A with two deals capturing an 8.7% share of the overall deal activity for the month.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

In terms of value of deals, venture financing was the leading category in Asia-Pacific’s medical devices industry with $177.36m, followed by M&A deals totalled $11.7m.

Asia-Pacific medical devices industry deals in October 2022: Top deals

The top five medical devices deals accounted for 82.8% of the overall value during October 2022.

The combined value of the top five medical devices deals stood at $156.49m, against the overall value of $189.1m recorded for the month.

The top five medical devices industry deals of October 2022 tracked by GlobalData were:

1) Chende Capital, SoftBank Vision Fund 2, Yiheng Capital Partners, Yuanyi Capital and Zhongwei Capital HoldingLimited’s $100m venture financing deal with Xunshi Technology

2) The $15m venture financing of Shenzhen Jinbaihui Biological by Bank of China Guangdong Finance

3) Longping Biosciences, Qianhai Great Wall Fund Management (Shenzhen) and Qiluo Investment’s $13.89m venture financing deal with Shenzhen Sailu Medical Technology

4) The $13.8m venture financing of Hangzhou Shenluo Medical Technology by Boyuan Capital and SDIC Chuanghe Fund Management

5) Changan Huitong, October Capital, Season Ventures and Yinglian Health Fund’s $13.8m venture financing deal with Zhejiang Pushkang Biotechnology